Stock screener

CLOV

Conviction 86HealthcareScan · Mon, Aug 10, 2026
CLOV$4.56-4.20%
ResistanceSupportVol 14Insider sell
63 bars
5
2
Vol MA14 5.06M
May 11May 28Jun 16Jul 6Jul 23Aug 10
CLOVER HEALTH INVESTMENTS, CORP. /DEHOSPITAL & MEDICAL SERVICE PLANSwww.cloverhealth.com ↗
Price4.56
Change-4.20%
Gap-1.26%
Rel volume2.27×
Avg volume4.96M
Avg $ vol22.38M
SMA 204.47
SMA 504.61
SMA 2003.03
Price vs 50-1.06%
Price vs 200+50.65%
MA stackmixed
50/200 cross—
Supertrenddown · 4.89
RSI (14)51
MACD hist0.02
MACD crossbull · 1d
Stoch %K / %D41 / 50
ADX (14)25
+DI / −DI27 / 18
RSI divergence—
MACD divergenceBullish
ATR %+6.48%
ADR %5.66%
52w high5.41
52w low1.70
From 52w high-15.71%
Above 52w low+168.24%
New 52w highNo
SqueezeOff
Bollinger width18.83%
%B0.61
Donchian pos41.12%
Donchian high5.19
Donchian low4.12
AVWAP (52w high)4.73
vs AVWAP high-3.66%
AVWAP (52w low)3.88
vs AVWAP low+17.39%
OBV trendFlat
Chaikin MF (20)-0.25
Today vs 20d2.27×
Avg vol (14d)5.06M
Avg vol (20d)4.96M
Avg $ vol (20d)22.38M
Market cap—
RS 3m (vs SPY)+63.10%
RS 6m (vs SPY)+119.22%
RS line new highNo
Trend template7/8
Technical rank74.2
1 week+5.31%
1 month+2.70%
3 months+46.15%
6 months+114.08%
1 year+106.33%
YTD+89.21%
P/E-28.43
P/B6.46
P/S1.26
P/FCF-35.26
EPS-0.4400
Div yield—
ROE-22.74%
ROA-11.88%
Debt/Eq0.00
Current1.50
EV/EBITDA-26.94
Gross margin13.37%
Net margin-4.45%
Rev growth40.34%
EPS growth-98.91%
Price target5.25
Target upside10.53%
Analyst ratingBuy
Institutional35.97%
Ent. value2.35B
Revenue743.17M
Net income28M
Gross profit81.21M
Free cash flow-68.98M
IndustryHOSPITAL & MEDICAL SERVICE PLANS
ExchangeNasdaq
Shares out430.97M
Employees724
ListedFri, Jan 8, 2021
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction86 / 100
Pattern quality—
Tech rank74.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.47
Support4.12
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Breaking out now
    Jun 9
    1 scan
  2. Setting up
    Jun 18
    1 scan
  3. Breaking out now
    Jun 22
    1 scan

Congress activity

Disclosed STOCK Act trades in CLOV

All disclosures →
No recent disclosed trades by Congress in CLOV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CLOV · 10 sells

InsiderSideShares
Reynoso Jamie L.
CEO, Medicare Advantage · Class A Common Stock · 2026-07-17
Sell4.84K
THORNTON JOSEPH CLAY
Interim CFO · Class A Common Stock · 2026-07-15
Sell4.63K
Soares Karen
Chief Legal Officer · Class A Common Stock · 2026-07-15
Sell10.52K
Reynoso Jamie L.
CEO, Medicare Advantage · Class A Common Stock · 2026-07-15
Sell13.12K
Wai Conrad
CEO, Counterpart Health · Class A Common Stock · 2026-07-15
Sell24.21K
Toy Andrew
Chief Executive Officer · Class A Common Stock · 2026-07-15
Sell62.71K
Reynoso Jamie L.
CEO, Medicare Advantage · Class A Common Stock · 2026-07-08
Sell2.38K
Reynoso Jamie L.
CEO, Medicare Advantage · Class A Common Stock · 2026-06-17
Sell2.36K
OLDAKOWSKI JOSEPH FRANK
VP OF FINANCE AND CONTROLLER · Class A Common Stock · 2026-06-16
Sell12.1K
Soares Karen
Chief Legal Officer · Class A Common Stock · 2026-06-15
Sell4.68K

SEC filings

EDGAR filings in CLOV · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.